Effects of Varenicline on Cortical Neuroplasticity and Working Memory in Patients With Schizophrenia and Healthy Controls

Trial Profile

Effects of Varenicline on Cortical Neuroplasticity and Working Memory in Patients With Schizophrenia and Healthy Controls

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Aug 2015

At a glance

  • Drugs Varenicline (Primary)
  • Indications Schizophrenia
  • Focus Pharmacodynamics
  • Acronyms VAR-PAS
  • Most Recent Events

    • 24 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 16 Jan 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 10 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top